• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Protamine neutralizes CSPG-mediated inhibition of oligodendrocyte differentiation

Bioengineer by Bioengineer
December 7, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: NIBB

Remyelination is a critical repair process in demyelinating diseases such as multiple sclerosis (MS). Chondroitin sulfate proteoglycans (CSPGs), a family of large molecules consisting of a core protein and glycosaminoglycans comsposed of chains of alternating sugars, are enriched in glial scars. In MS lesions, CSPGs accumulate as constituents of demyelinating plaques, which inhibit the migration and differentiation of oligodendrocyte precursor cells and remyelination.

The research group of Researcher Akihiro Fujikawa and Professor Masaharu Noda of the National Institute for Basic Biology (NIBB) developed a screening method to obtain neutralizing agents for canceling the inhibitory effects of CSPGs on oligodendrocyte differentiation. The group found that the inhibitory activity of a representative extracellular matrix CSPG molecule, aggrecan, was neutralized by a polycationic peptide, protamine, that is clinically used to stop the anticoagulant effect of heparin.

They also found that protamine inhibited a receptor-type protein tyrosine phosphatase, PTPRZ. The extracellular region of PTPRZ is highly modified with CS chains and its phosphatase activity contributes to maintain immature states of oligodendrocyte precursor cells. Intranasal administration of protamine enhanced myelination in the developing mouse brain, and its intraventricular administration significantly improved the remyelination of cuprizone-induced lesions in adult mice.

These results suggest that protamine neutralizes the inhibitory activity of CSPGs, thereby permitting migration of oligodendrocyte precursor cells into demyelinating sites and promoting their differentiation to mature oligodendrocytes for remyelination.

The results of this research were published in PLOS ONE on Dec 7, 2017.

###

PLOS ONE
"Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation"
Kazuya Kuboyama, Naomi Tanga, Ryoko Suzuki, Akihiro Fujikawa, and Masaharu Noda
DOI: https://doi.org/10.1371/journal.pone.0189164

National Institute for Basic Biology
http://www.nibb.ac.jp/en/

Media Contact

NIBB Office of PR
[email protected]
81-564-557-628

http://www.nins.jp/english/

Related Journal Article

http://dx.doi.org/10.1371/journal.pone.0189164

Share12Tweet8Share2ShareShareShare2

Related Posts

FGFR2b Links to Biomarkers, Tumor Diversity, Survival

April 1, 2026

Frailty, Malnutrition Link Falls to Daily Functioning

April 1, 2026

Dactylides D, E: Novel 22-Membered Polyol Macrolides

April 1, 2026

Longer Leukocyte Telomeres Linked to Premature Membrane Rupture

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

FGFR2b Links to Biomarkers, Tumor Diversity, Survival

Frailty, Malnutrition Link Falls to Daily Functioning

Dactylides D, E: Novel 22-Membered Polyol Macrolides

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.